To get the latest CME stock quote, you can visit the CME Group's website and click on the "Quotes" tab. This will give you the current stock price and other relevant information.
The CME Group is a leading global exchange, with a market capitalization of over $80 billion. It's a major player in the financial industry.
To get a more in-depth analysis of the CME stock, you can check out financial websites such as Yahoo Finance or Google Finance. These websites provide up-to-date information on the stock's performance and trends.
CME stock is listed on the NASDAQ exchange under the ticker symbol CME.
Discover more: Google Finance Stocks Stock Quotes
Stock Information
CME stock has shown impressive financial performance in recent years. In 2023, the revenue increased by 11.19% to $5.57 billion, with earnings rising by 19.89% to $3.19 billion.
The company's revenue growth is reflected in its stock performance, with a 1.13% increase in the current year. The 1-day and 1-week performance show a -0.82% and +1.12% change, respectively.
Here are the key financial metrics for CME Group Inc.:
CME Group's valuation metrics show a capitalization of $85.39 billion in 2024, with a P/E ratio of 24.8x. The enterprise value is $86.42 billion, and the EV/Sales ratio is 14.2x.
Historical Prices
CME Group's stock price has seen significant fluctuations over the past year. The 52-week low was $190.70 on June 18, 2024, while the 52-week high was $249.02 on December 5, 2024.
Here's a breakdown of the stock's performance over the past few months:
CME Group's revenue has been steadily increasing, with a 11.19% growth in 2023 compared to the previous year.
Options Overview Details
Let's dive into the options overview details. Implied volatility is currently at 19.23%, which is a slight decrease from the previous day's value.
The historical volatility of the stock is 15.50%. This means that the stock's price has been volatile in the past, and investors should be prepared for potential price swings.
The IV percentile is 59%, which indicates that the current implied volatility is slightly above average. The IV rank is 40.04%, which is a measure of how the current implied volatility compares to historical values.
A fresh viewpoint: Meme Stock Price
The put/call volume ratio is 0.66, indicating that there are more call options being traded than put options. Today's trading volume is 557, which is lower than the 30-day average of 1,457.
Here's a summary of the key statistics:
The put/call open interest ratio is 0.44, indicating that there are more call options open than put options. Today's open interest is 32,442, which is lower than the 30-day average of 38,776.
Worth a look: Incentive Stock Options
Hard Red Spring Wheat
Hard Red Spring Wheat is a type of wheat that will be traded on the CME Group's derivatives marketplace, with futures and options set to launch.
The CME Group, the world's leading derivatives marketplace, has announced its plans to launch physically-delivered Hard Red Spring Wheat futures and options.
For your interest: Penny Options Stocks
The Big 3: BLK, VMC
BLK, or BlackRock, has seen significant upside growth off post-election anticipation. Financials and materials have taken focus in today's market.
BLK is a global investment management company with over $7 trillion in assets under management. It's a leader in the financial sector.
VMC, or Vulcan Materials Company, is a leading producer of construction aggregates. It's a key player in the materials sector.
BLK and VMC have both seen significant growth in recent times, outperforming the market. Their stocks have been on the rise due to increased demand for construction materials and financial services.
BLK's stock price has increased by over 20% in the past year, making it a standout performer in the financial sector.
Curious to learn more? Check out: Umb Financial Stock
Investor Insights
CME Group is the largest futures exchange in the world, with a market share of around 93% of the US futures market.
The company's stock, CME, is listed on the NASDAQ stock exchange under the ticker symbol CME.
CME Group's revenue comes primarily from transaction fees, which are charged on every trade executed on its exchanges.
The company's most popular product is likely the E-mini S&P 500 futures contract, which is based on the S&P 500 stock index.
In 2020, CME Group's average daily volume was around 17.1 million contracts.
The company's stock has historically been considered a defensive play, meaning it tends to perform well during times of economic uncertainty.
For more insights, see: Stock Market Falling
Company Data
CME Group's financial performance has been impressive, with revenue increasing by 11.19% in 2023 to $5.57 billion.
In 2023, CME Group's earnings were $3.19 billion, a significant increase of 19.89% compared to the previous year.
Here's a breakdown of CME Group's net sales and net income in 2024 and 2025:
CME Group's net debt has been steadily increasing, reaching $1.68 billion in 2025.
Company Profile
CME Group is one of the world's leading stock market brands.
The company's profile is marked by its global presence, with a strong reputation in the financial industry. This reputation is built on the company's long history of providing reliable and efficient trading services.
CME Group has a rich history that spans many decades, but the exact number of years is not specified in the article sections.
Financials
CME Group's financial performance has been impressive, with revenue increasing to $5.57 billion in 2023, a 11.19% rise from the previous year. This growth is a testament to the company's strong market position.
In 2024, the company's net sales were $6.1 billion, with a projected increase to $6.26 billion in 2025. The net income also saw a steady rise, from $3.46 billion in 2024 to $3.52 billion in 2025.
The company's net debt has been fluctuating, standing at $1.03 billion in 2024 and projected to reach $1.68 billion in 2025. This increase in net debt is a concern, but the company's strong revenue growth suggests it can manage its debt.
Here's a breakdown of CME Group's financial performance:
CME Group's financial performance is a reflection of its strong market position and ability to adapt to changing market conditions.
Market Analysis
The current CME stock quote is showing some interesting trends. The Barchart Technical Opinion rating is a 80% Buy, indicating a strong potential for growth.
We should be cautious, however, as the short term outlook is weakening. This means that the current direction may not be sustainable in the near future.
Long term indicators, on the other hand, fully support a continuation of the trend. This suggests that the growth potential is still strong, even if the short term outlook is uncertain.
The market is approaching overbought territory, which means that it's getting close to being too high. This can be a sign of a potential trend reversal, so we should be watchful of any changes in the market.
News and Updates
CME Group's stock price target has been adjusted by several analysts, with TD Cowen setting a new target of $253, while Morgan Stanley raised its target to $256. CME's international average daily volume rose 14% in 2024.
Several analysts have adjusted their price targets for CME Group, with Deutsche Bank setting a new target of $245 and Piper Sandler raising its target to $258. CME Group's Board of Directors has approved a $2.1 billion annual variable dividend and a $3 billion share repurchase program.
Here's a summary of the price target adjustments for CME Group:
- TD Cowen: $253
- Morgan Stanley: $256
- Deutsche Bank: $245
- Piper Sandler: $258
Latest News:
CME Group Inc. has been in the news lately, with several updates and announcements. CME Group Insider bought shares worth $325,798, according to a recent SEC filing.
TD Cowen has adjusted its price target on CME Group to $253 from $257, while maintaining a Hold rating. Morgan Stanley has also adjusted its price target to $256 from $236, keeping an Equalweight rating.
CME Group's international average daily volume has risen 14% in 2024. This is a significant increase, and it's likely due to the company's efforts to expand its global presence.
Here are some key updates on CME Group's stock price target adjustments:
CME Group is also expanding its product offerings, with plans to launch hard red spring wheat futures and options in Q2. This is a significant move, and it's likely to attract new customers and increase trading volumes.
Announces Reference Rates
CME Group has announced it will provide CME Term €STR Reference Rates to meet client demand for a term reference rate.
This move is likely a response to growing demand from clients for more accurate and reliable reference rates.
The CME Group is the world's leading derivatives marketplace, making this announcement significant in the financial sector.
The company has a strong track record of innovation and meeting client needs, which is evident in this announcement.
Frequently Asked Questions
Is CME Group a good investment?
According to Wall Street research, CME Group is considered a "hold" stock, with a neutral consensus among analysts. However, with 4 buy ratings and 4 sell ratings, it's worth exploring the details to make an informed investment decision.
How does CME make money?
CME Group generates revenue through transaction fees charged on trades executed on its derivatives marketplace, earning a percentage of each trade's value. This business model allows CME to profit from the buying and selling of various financial instruments.
What is the forecast for CME stock price?
According to 15 Wall Street analysts, the average 12-month forecast for CME stock price is $239.67, representing a 2.64% change from the current price. This forecast ranges from a low of $181.00 to a high of $275.00.
Is the CME Group publicly traded?
Yes, the CME Group is a publicly traded company, listed on the NASDAQ stock exchange. Its unique ownership structure and history of mergers and acquisitions contribute to its atypical corporate governance.
Featured Images: pexels.com